Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-03-06

FDA Approved: TROGARZO — Original Application (Theratechnologies Inc.)

View source ↗

Summary

The FDA approved TROGARZO (ibalizumab) as the original application for treatment of adults with multidrug-resistant HIV-1 infection who are heavily treatment-ex…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trogarzo (ibalizumab)

Snippet

ORIG AP for TROGARZO (IBALIZUMAB)